Assay News and Research

RSS

Targeting lipA for Precise Management of Bacterial Outbreaks in Intensive Aquaculture

Bacterial diseases pose persistent challenges for intensive aquaculture, where outbreaks can damage fish health and cause substantial economic losses.

11 Nov 2026

Could a Swallowed Robotic Capsule Replace Insulin Injections?

This study presents a biodegradable robot that delivers insulin directly to the intestine, achieving delayed release and lowering blood sugar in pig models.

6 Nov 2026

Virtual Reality Imaging Uncovers Olfactory Gated Visual Acuity in Flies

Imagine a crowded dance floor where bodies move to the beat beneath a glittering disco ball. Some of the dancers pair up, drawn together by the heady atmosphere.

5 Nov 2026

ATCC Selected by ARPA-H to Support Next-Generation BioStabilization Technologies

ATCC has been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an affiliate to provide independent verification and validation (IV&V) for its BioStabilization Systems (BoSS) program.

29 Oct 2026

OGT Launches First Fusion MRD NGS Panel for AML to Expand Fusion Detection at MRD-Level Sensitivity

OGT, a leading global provider of genomic research and diagnostic solutions, today announced the launch of the SureSeq™ myPanel Myeloid Fusion MRD Panel, the first-to-market dedicated fusion MRD next-generation sequencing (NGS) panel for acute myeloid leukemia (AML).

27 Oct 2026

New Genetic Map Identifies Variations Linked to Long QT Syndrome

Using an innovative, high-throughput technique, an international collaboration led by Vanderbilt Health researchers has created a "map" of 1,757 genetic variations that can trigger a life-threatening heart rhythm disorder called long QT syndrome.

24 Oct 2026

Promega UK Launches Lumit® Insulin Immunoassay

A new homogeneous, wash-free, plate-based assay that enables researchers to rapidly measure insulin secretion using a simple add-and-read format, delivering robust results ideal for metabolic disease drug discovery.

From Promega Corporation 22 Oct 2026

Genetic Clue to Autism's Fourfold Difference In Boys and Girls

Findings on MECP2 regulatory variants suggest genetic factors contribute to autism's male bias, enhancing understanding of the disorder's heritability.

22 Oct 2026

New DNA Test Detects Listeria in Ice Cream and Reveals How It Survives Freezing

Researchers developed a PMA-ddPCR assay to detect and quantify potentially viable Listeria monocytogenes in ice cream, identifying the pathogen in two of 500 commercial samples and demonstrating good agreement with conventional culture-based measurements. The method also supported predictive models of bacterial growth under different temperature conditions, while experiments showed that the pathogen could survive 240 days of frozen storage without substantial changes in population levels.

21 Oct 2026

Improving CRISPR-Based Diagnostics for Sensitive Detection of Infectious RNA Viruses

Scientists have long used a powerful gene-editing tool called CRISPR to make precise changes to DNA.

14 Oct 2026

Vitalant Launches Cell-Based Analytics Lab to Support Allogeneic Therapy Developers

Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organizations, today announced the launch of its analytics lab at the Phoenix Bioscience Core, expanding its cell and gene therapy (CGT) analytical capabilities for developers of allogeneic cell therapies.

7 Oct 2026

Scientists Discover Why High Levels of the Amino Acid Cysteine Are Toxic to Cells

Cysteine is one of the main building blocks that cells use to make proteins. But this amino acid is a double-edged sword–too much cysteine is toxic to the cell.

24 Sep 2026

Fuse Diagnostics Raises £1 Million to Scale Rapid Point-of-Need Molecular Testing Platform

Fuse Diagnostics (“Fuse”), a developer of next-generation molecular diagnostics for point-of-need testing, today announced it has raised £1 million to accelerate commercialization of its proprietary Flip™ product platform and expand manufacturing capabilities at its headquarters in Cambridge, UK.

16 Sep 2026

Multi-Omic Integration Reveals Novel Gene-Disease Links in Undiagnosed Rare Conditions

Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité (BIH) and Genomics England have shown that measuring proteins in the blood can provide important additional clues about the effects of genetic variants, helping to identify diagnoses and potential new disease-causing genes that genome sequencing alone has been unable to resolve.

10 Sep 2026

Research Identifies Microorganisms That Convert Precursors Into Testosterone

Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease often try to reduce testosterone production or block its effects.

7 Sep 2026

Colorectal Cancer and Nerve Damage: A Hidden Link Uncovered in Mice and Primates

Colorectal tumors trigger inflammatory nerve damage, suggesting cancer itself may be a risk factor for neuropathy in survivors, independent of treatments.

27 Aug 2026

Antibodies for Visualizing Cell Identity and Tumor Architecture

Whether you are characterizing cell state transitions, assessing organelle integrity, or building a multiplex immunofluorescence (IF) assay, you need reliable structural markers for your imaging.

From Antibodies Incorporated 21 Aug 2026

DeNovix Releases CellGlow, the Instant Cell Viability Assay

DeNovix Inc. announces the release of CellGlow, a new ready-to-use viability assay for automated cell counting.

From DeNovix Inc. 29 Jul 2026

Deep-Learning Holography Detects Elusive Circulating Tumor Cells in Prostate Cancer

Researchers combined microfluidic enrichment, AI-assisted holography, and fluorescence profiling to identify circulating tumor cell candidates in 13 men with metastatic castration-resistant prostate cancer and 8 healthy donors. The platform found higher median candidate counts in patients, while nearly two-thirds of PSMA-positive candidates lacked EpCAM, suggesting EpCAM-dependent assays could miss some cells.

27 Jul 2026

AI-Assisted Paper Test Measures Three Cardiac Biomarkers in 23 Minutes

Researchers developed an AI-assisted dual-mode paper assay that measures cTnI, CK-MB, and NT-proBNP from 50 µL of serum in 23 minutes. In single-site analytical validation, neural networks quantified the three biomarkers across distinct concentration ranges, supporting further development for multiplexed cardiac testing at the point of care.